Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Psyllium Husk Powder, Quantity: 568 mg/g
Procter & Gamble Australia Pty Ltd
Psyllium Husk Powder
Oral Liquid, powder for
Excipient Ingredients: brilliant blue FCF; allura red AC; citric acid; malic acid; aspartame; maltodextrin; acesulfame potassium; Flavour
Oral
72 doses, 48 doses, 1.06kg 180 doses, 673g 114 doses
Medicine Registered
Not scheduled. Not considered by committee
Management of chronic constipation; constipation in irritable bowel syndrome; as adjunctive therapy in diverticular disease; in the bowel management of patients with haemorrhoids; and for constipation during pregnancy, convalescence and senility. Diets low in saturated fat and cholesterol that include 7 grams of soluble fibre from psyllium husk, as in Metamucil, may lower cholesterol levels. Reductions in cholesterol may contribute to reducing the risk of heart disease.
Visual Identification: powder; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2008-06-18